Quillivant XR 25 MG/5 ML susp 120ML
Ended Awarded
- Contract number
- SPE2DB25FY9QT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,160
Award facts
- Contract value 100% obligated
- $4,159.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $4,159.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension (120 ml). This delivery order, which carries an ultimate completion date of August 20, 2025, was competitively awarded with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills a critical role in the federal medical supply chain, particularly for Defense Health Agency and military healthcare systems. The company's extensive portfolio with the DLA encompasses a wide range of pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. Quillivant XR, a methylphenidate-based medication used for attention-deficit/hyperactivity disorder treatment, demonstrates the company's capability to supply specialized pharmaceutical commodities to support military healthcare needs.
Quick answers
Who was awarded contract SPE2DB25FY9QT?
SPE2DB25FY9QT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 19, 2025.
How much is contract SPE2DB25FY9QT worth?
The government has obligated $4,160 on SPE2DB25FY9QT.
Is contract SPE2DB25FY9QT an order under another contract?
Yes. SPE2DB25FY9QT is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY9QT competed?
The extent of competition for SPE2DB25FY9QT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award